Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1970 1
1971 2
1985 2
1987 1
1989 1
1990 1
1992 1
1993 1
1994 1
1996 2
1997 1
1999 1
2000 1
2001 4
2002 3
2003 8
2004 11
2005 14
2006 16
2007 7
2008 14
2009 13
2010 17
2011 24
2012 43
2013 24
2014 34
2015 88
2016 42
2017 55
2018 85
2019 118
2020 45
2021 11
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

532 results

Results by year

Filters applied: . Clear all
Page 1
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.
Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M, Ordemann R, Qayed M, Renteria AS, Reshef R, Wölfl M, Chen YB, Goldstein S, Jagasia M, Locatelli F, Mielke S, Porter D, Schechter T, Shekhovtsova Z, Ferrara JL, Levine JE. Harris AC, et al. Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10. doi: 10.1016/j.bbmt.2015.09.001. Epub 2015 Sep 16. Biol Blood Marrow Transplant. 2016. PMID: 26386318 Free PMC article.
Graft-versus-host disease.
Bron D. Bron D. Curr Opin Oncol. 1994 Jul;6(4):358-64. doi: 10.1097/00001622-199407000-00006. Curr Opin Oncol. 1994. PMID: 7803536 Review.
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
Ijaz A, Khan AY, Malik SU, Faridi W, Fraz MA, Usman M, Tariq MJ, Durer S, Durer C, Russ A, Parr NNC, Baig Z, Sagar F, Ali Z, McBride A, Anwer F. Ijaz A, et al. Biol Blood Marrow Transplant. 2019 Jan;25(1):94-99. doi: 10.1016/j.bbmt.2018.08.028. Epub 2018 Sep 6. Biol Blood Marrow Transplant. 2019. PMID: 30195074 Free PMC article. Review.
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
Pasic I, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Mattsson J, Michelis FV. Pasic I, et al. Ann Hematol. 2020 Jun;99(6):1377-1387. doi: 10.1007/s00277-020-04033-2. Epub 2020 May 7. Ann Hematol. 2020. PMID: 32382774
Chronic graft-versus-host disease (GVHD) in children.
Baird K, Cooke K, Schultz KR. Baird K, et al. Pediatr Clin North Am. 2010 Feb;57(1):297-322. doi: 10.1016/j.pcl.2009.11.003. Pediatr Clin North Am. 2010. PMID: 20307722 Free PMC article. Review.
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.
Pidala JA, Hamilton BK, Martin PJ, Onstad L, Storer BE, Palmer J, Alousi A, Cutler C, Jagasia MH, Chen GL, Arora M, Flowers ME, Lee SJ. Pidala JA, et al. Biol Blood Marrow Transplant. 2019 Dec;25(12):2468-2473. doi: 10.1016/j.bbmt.2019.07.040. Epub 2019 Aug 5. Biol Blood Marrow Transplant. 2019. PMID: 31394265 Free PMC article. Clinical Trial.
Impact of graft-versus-host disease on survival.
Pasquini MC. Pasquini MC. Best Pract Res Clin Haematol. 2008 Jun;21(2):193-204. doi: 10.1016/j.beha.2008.02.011. Best Pract Res Clin Haematol. 2008. PMID: 18503986 Review.
532 results